Navigation Links
Janssen Research & Development Submits Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome
Date:12/29/2011

RARITAN, N.J., Dec. 29, 2011 /PRNewswire/ -- Janssen Research & Development, LLC (JRD) announced today that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of XARELTO® (rivaroxaban), an oral anticoagulant, to reduce the risk of (thrombotic) cardiovascular events in patients with Acute Coronary Syndrome (ACS).

The filing is supported by data from the pivotal Phase 3 ATLAS ACS 2 TIMI 51 (Anti-Xa Therapy to Lower cardiovascular events in Addition to aspirin with/without thienopyridine therapy in Subjects with Acute Coronary Syndrome) trial, which was presented in November at the American Heart Association Scientific Sessions and published in the New England Journal of Medicine (10.1056/NEJMoa1112277).

ACS is a complication of coronary heart disease, which is the leading cause of death in the U.S. and also one of the most prevalent non-communicable diseases in the world. ACS occurs when a blood clot blocks a coronary artery, reducing blood supply to the heart. This disruption of blood flow can cause a heart attack, or unstable angina, a condition signifying that a heart attack may soon occur. Each year, an estimated 1.2 million patients in the U.S. are discharged from the hospital with a primary or secondary diagnosis of ACS.

About XARELTO® (rivaroxaban)

XARELTO® belongs to a group of medicines called anticoagulants, and works by blocking the blood clotting Factor Xa, thereby reducing the tendency to form clots. In the U.S., XARELTO® is indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE) in people undergoing knee or hip replacement surgery, and for reducing the risk of stroke and systemic e
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Record Breaking $327 Million Verdict Upheld in Janssen Case and Request for New Trial Denied
2. Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations
3. Pharmacyclics Forms Pact to Develop and Commercialize PCI-32765 for Hematologic Cancers with Janssen Biotech, Inc.
4. Janssen Pharmaceuticals, Inc. Launches Online Tools on PrescribeResponsibly.com
5. Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division
6. Dr. Napoleone Ferrara Wins 2011 Dr. Paul Janssen Award for Biomedical Research
7. Janssen Products, LP Modifies Prescribing Information for PROCRIT® (Epoetin alfa) in Chronic Kidney Disease
8. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
9. Record Breaking $327 Million Verdict Announced in Janssen Case
10. MHPA Center for Best Practices Receives Sponsorship from Ortho-McNeil Janssen Pharmaceuticals, Inc. to Improve Medicaid Quality, Care Coordination for Serious Mental Illness
11. Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... and CAMBRIDGE, Mass., May 28, 2015  Shareholder rights ... whether certain officers and directors of Eleven ... shareholders.  Eleven Biotherapeutics is a clinical-stage biopharmaceutical company ... protein therapeutics to treat eye diseases, primarily in ... View this press release on the ...
(Date:5/28/2015)... May 27, 2015 The amount Americans spend ... 2014 and with growth of 8% will reach $608 ... of pocket: directly on expenditures, co-pays as part of ... on premiums.  The publisher made its finding in its ... the United States . ...
(Date:5/28/2015)... -- A new report by Allied Market ... Opportunities, Growth and Forecast, 2014-2020", forecasts the global syphilis ... secondary syphilis testing would continue to be the largest ... , Middle East & ... 43% revenue share of the global syphilis testing market ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of Eleven Biotherapeutics, Inc. (EBIO) on Behalf of Shareholders 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 2Report: U.S. Out-of-Pocket Healthcare Spending Reaches $416 Billion 3Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 2Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 3
... Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the ... for cancer, announced today that H. Shep Wild, President ... at the Biotechnology Industry Organization,s 10 th Annual ... October 26 at 9:00 am. The BIO ...
... Luminex Corporation (NASDAQ: LMNX ... Deloitte,s 2011 Technology Fast 500™, a ranking of the ... technology companies in North America. Rankings are based on ... (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ...
Cached Medicine Technology:CureFAKtor Pharmaceuticals to Present at 10th Annual BIO Investor Forum 2Luminex Corporation Receives Deloitte Technology Fast 500™ Award 2Luminex Corporation Receives Deloitte Technology Fast 500™ Award 3
(Date:5/28/2015)... 2015 Today the National Resident Matching ... the 2015 Main Residency Match®. A record-number 30,212 ... filled when the matching algorithm was processed. Of ... the Match Week Supplemental Offer and Acceptance Program® (SOAP®) ... pleased with the outcome of the 2015 Main Residency ...
(Date:5/28/2015)... Los Angeles, Calif. (PRWEB) May 28, 2015 ... announces its selection by ContentChecked (CNCK) as its ... ContentChecked’s latest health and nutrition app, SugarChecked. SugarChecked ... consumers to better understand the potential sugars they ... be responsible for the launch of SugarChecked, execute ...
(Date:5/28/2015)... 28, 2015 Park Cities Pet Sitter is ... Training class starting Saturday, June 6th at 10:30am. ... 5831 McCommas Blvd in Dallas, with a maximum of six ... for five weeks, with no class being held over the ... $135. , In this Intermediate-to-Advanced level class, dogs will solidify ...
(Date:5/28/2015)... Dr. Jenyons’ Medical Weight Loss & Rejuvenation ... looking to undergo its advanced Micro-Needling skin rejuvenating procedure. ... able to get a single Micro-Needling treatment with plasma, ... three-treatment package, which costs $1,800, the clinic will add ... Juanita Jenyons, M.D., says Dr. Jenyons’ Medical Weight Loss ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Ross A. ... surgeon , has hired Teresa Beard as the new ... her role, Beard will oversee all marketing and promotional ... of experience leading teams and developing compelling marketing strategies ... and Body Specialists, Beard served as guest communication manager ...
Breaking Medicine News(10 mins):Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 3Health News:ContentChecked Selects PMBC Group To Launch New Nutrition App SugarChecked 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 3Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 3Health News:Clevens Face and Body Specialists Welcomes Teresa Beard as Marketing Director 2
... ... of America (CHCA) to provide employee and physician surveys and consulting services through October ... ... today its agreement with Child Health Corporation of America (CHCA) to provide employee and ...
... ... platform to derive actionable insights from all forms of qualitative customer feedback , ... (PRWEB) March 10, 2010 ... general availability of their Customer Experience Analytics (CxA) solution under a SaaS model. ...
... , ... for new medical equipment continues to increase among heath care facilities. QuickMedical has recognized ... of leasing new medical equipment versus paying cash or long-term high interest rate financing., ... Issaquah, WA ...
... Nationwide study finds number ... , ... the U.S., over 45% of dogs and 58% of cats are now estimated to be overweight ... Obesity Awareness Day Study, conducted in October 2009, found that from 2007 to 2009, the number ...
... ... 32nd annual Artexpo New York. Renea’s sculpted oil paintings display the intricate interface ... textured oasis. Art enthusiasts say her use of oils creates a thick and ... work. Each of the swirls she creates takes the viewer on another journey ...
... ... ... , ... , , , , ...
Cached Medicine News:Health News:Morehead Associates, Inc. and Child Health Corporation of America (CHCA) ,Finalize Agreement for Employee and Physician Surveys and Consulting Services 2Health News:Morehead Associates, Inc. and Child Health Corporation of America (CHCA) ,Finalize Agreement for Employee and Physician Surveys and Consulting Services 3Health News:Serendio Announces SaaS-based Customer Experience Analytics (CxA) Solution 2Health News:Serendio Announces SaaS-based Customer Experience Analytics (CxA) Solution 3Health News:QuickMedical Launches Medical Equipment Lease Program With Providence Capital 2Health News:QuickMedical Launches Medical Equipment Lease Program With Providence Capital 3Health News:QuickMedical Launches Medical Equipment Lease Program With Providence Capital 4Health News:Pet Obesity Continues to Grow in U.S. 2Health News:Pet Obesity Continues to Grow in U.S. 3Health News:Pet Obesity Continues to Grow in U.S. 4Health News:Red Hot Artist Renea Menzies Has Flower Power; Houston, Texas Artist Renea Menzies Showcases Her Work in NY 2Health News:Red Hot Artist Renea Menzies Has Flower Power; Houston, Texas Artist Renea Menzies Showcases Her Work in NY 3Health News:Justice Department Files for Immediate Relief Regarding Conditions at Conway Human Development Center, in Conway, Arkansas 2Health News:Justice Department Files for Immediate Relief Regarding Conditions at Conway Human Development Center, in Conway, Arkansas 3Health News:Justice Department Files for Immediate Relief Regarding Conditions at Conway Human Development Center, in Conway, Arkansas 4
... The Dimension Vista 1500 integrated ... nephelometry, IMT (integrated multisensor technology) ... design will integrate analysis of ... drugs-of-abuse, therapeutic drugs, immunosuppressive drugs, ...
... flexibility to floor-mounted X-ray systems. The ... the C-arm around the exam table ... angle for cardiac and general angiography. ... flat panel detector that delivers outstanding ...
... simplified In-office. Information. In real time. The FemExam ... of elevated vaginal fluid pH (pH >= 4.7) ... format is easy to use and delivers accurate ... rub a swab containing unprocessed vaginal fluid across ...
The Polygraf ID multi-parametric recorder works with POLYGRAM NET analysis software to create a unique interface that combines web-style navigation, graphical presentation and intuitive design to del...
Medicine Products: